Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Treasury Shares (2021 - 2025)

PAVmed (PAVM) has 1 years of Treasury Shares data on record, last reported at $408000.0 in Q4 2022.

  • For Q3 2025, Treasury Shares changed N/A year-over-year to $2.0 million; the TTM value through Sep 2025 reached $2.0 million, changed N/A, while the annual FY2024 figure was $324431.0, 86.12% down from the prior year.
  • Treasury Shares reached $2.0 million in Q3 2025 per PAVM's latest filing, up from $322399.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.9 million in Q2 2024 and bottomed at $111109.0 in Q4 2021.
  • Average Treasury Shares over 5 years is $1.4 million, with a median of $975000.0 recorded in 2022.
  • Peak YoY movement for Treasury Shares: skyrocketed 1782.31% in 2022, then crashed 91.73% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $111109.0 in 2021, then surged by 1782.31% to $2.1 million in 2022, then grew by 11.76% to $2.3 million in 2023, then plummeted by 86.12% to $324431.0 in 2024, then soared by 526.75% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $408000.0 in Q4 2022, $408000.0 in Q3 2022, and $548000.0 in Q2 2022.